Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by EyeDontBelieveU on Jan 12, 2017 11:31am

Here you go

RBC CAPITAL MARKETS


Downside scenario

Our $0 downside scenario utilizes a 7.2x multiple on 2018E Adj. EBITDA of $418MM (prev. $422MM), generating a value of $0.00. This scenario assumes slightly lower than anticipated portfolio demand and assumes the equity loses all value. We also assume increased AMCo competition and lower Donnatal demand. 

Comment by trivela on Jan 12, 2017 11:48am
What the heck! A 7.2 multiple! Why not a 6.95, or 7.15, or even a 7.05 multiple! Shorts are salivating with this kind of "research"! This is a typical half full/half empty glass scenario. Let me just remind that the first debt maturity is the bank debt (dollar and pound) and it is .... in 2021. So we have to wait for 2017, 2018, 2019 and 2020 to see if the company will default .... At ...more  
Comment by rad10 on Jan 12, 2017 11:55am
Which is why the secured first lien got me salivating......................  Effective yield of 11% until doomsday around 2020
Comment by EyeDontBelieveU on Jan 12, 2017 12:10pm
Wrong.  Coupon on the 9.5 notes is due in a few days.  The 2nd earn out payment is due in two weeks.  The bridge loan is due in Oct 2017 or the interest rate jumps to 11%
Comment by EyeDontBelieveU on Jan 12, 2017 12:13pm
  Oh and I didn't mention the coupon payments due on the other 7% notes or the first lien notes.    They have to service the debt.  That is what the shorts do not think will be possible with the declining revenues from their drug portfolio and the potential CMA fines and regulatory risk of Donnatal.
Comment by rad10 on Jan 12, 2017 12:14pm
  True - but these are all doable.  Question is how long can they keep going. Any recapitalisation the equity and unsecured are gone.................
Comment by trivela on Jan 12, 2017 12:41pm
They have $410 in cash, anticipated EBITDA or $400 in 2017, how on earth will they have any difficulty paying down the earn-outs or even the bridge loans (the bridge loans represent more or less $120 million)? By the way: the bridge loans "cost" $13 million in annual interest, so, if they pay the bridge loans this year, interest expense will decline a bit. They also have to do mandatory ...more  
Comment by Health123 on Jan 12, 2017 1:51pm
It you believe that they can service the debt with fake EBITDA, then why don't you buy the bonds?   38% yield is amazing, don't you think?  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities